Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study. da Silva TN, Rodrigues R, Saramago A, Pires C, et al. Eur J Endocrinol 2023;188:lvac011.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

da Silva TN, Rodrigues R, Saramago A, Pires C, et al. Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study. Eur J Endocrinol 2023;188:lvac011.
PMID: 36651156